Skip to main content
SpringerLink
Log in

Efalizumab

First report of eczematous rash and thrombocytosis: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Firmin D, Roguedas AM, Lemasson G, Abgrall JF, Misery L.Eczematous dermatosis and thrombocytosis induced by efalizumab: two new side effects. Dermatology 217: 203-206, No. 3, 2008 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Efalizumab. React. Wkly. 1227, 11 (2008). https://doi.org/10.2165/00128415-200812270-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812270-00031

Keywords

Search

Navigation